Back
Range Cancer Therapeutics ETF Vs. Amplify Treatments, Testing and Adv ETF Industry Stock Comparison
Sell
50
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.10
Seasonality Move:
3.41%
Buy
70
GERM
Amplify Treatments, Testing and Adv ETF
Last Price:
19.06
Seasonality Move:
10.7%
Sell
50
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.20. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Amplify Treatments, Testing and Adv ETF (GERM)
is a Buy
Is Amplify Treatments, Testing and Adv ETF a Buy, Sell or Hold?
- The current Amplify Treatments, Testing and Adv ETF [GERM] share price is $19.23. The Score for GERM is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- GERM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GERM Stock Price Chart
What is Amplify Treatments, Testing and Adv ETF's stock price today?
-
The Amplify Treatments, Testing and Adv ETF share price today is $19.23
The current trend is moderately bullish and GERM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 49.67 | Sell |
| Chaikin Money Flow: | 16655 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.4 - 15.46) | Buy |
| Bollinger Bands (100): | (14.08 - 16.42) | Sell |
GERM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 274 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.7 - 18.68) | Buy |
| Bollinger Bands (100): | (17.52 - 19.16) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.15 | Buy |
| 20-day SMA: | 15.03 | Buy |
| 50-day SMA: | 15.53 | Sell |
| 200-day SMA: | 13.22 | Buy |
| 8-day EMA: | 15.19 | Buy |
| 20-day EMA: | 15.18 | Buy |
| 50-day EMA: | 15.27 | Sell |
| 200-day EMA: | 14.17 | Buy |
GERM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.77 | Buy |
| 20-day SMA: | 17.97 | Buy |
| 50-day SMA: | 17.89 | Buy |
| 200-day SMA: | 18.15 | Buy |
| 8-day EMA: | 18.88 | Buy |
| 20-day EMA: | 18.3 | Buy |
| 50-day EMA: | 18.04 | Buy |
| 200-day EMA: | 18.63 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amplify Treatments, Testing and Adv ETF Earnings Growth & GERM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amplify Treatments, Testing and Adv ETF Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||